Aggrenox (Aspirin / Extended-Release Dipyridamole) - Summary

AGGRENOX SUMMARY

Aggrenox®
(aspirin/extended-release dipyridamole)
25 mg/200 mg capsules

AGGRENOX^® (aspirin/extended-release dipyridamole) is a combination antiplatelet agent intended for oral administration. Each hard gelatin capsule contains 200 mg dipyridamole in an extended-release form and 25 mg aspirin, as an immediate-release sugar-coated tablet.

AGGRENOX (aspirin/extended-release dipyridamole) is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.

AGGRENOX NEWS HIGHLIGHTS

Media Articles Related to Aggrenox (Aspirin / Dipyridamole)

GI Bleeding Associated With Worse Ischemic Stroke Outcomes
Source: MedPage Today Gastroenterology [2008.08.06]

Antipsychotics Confirmed to Increase Stroke Risk in Elderly
Source: MedPage Today Neurology [2008.08.29]

Gene May Put Women With Migraine At Increased Risk Of Heart Disease And Stroke
Source: Headache / Migraine News From Medical News Today [2008.07.31]

more>>

Published Studies Related to Aggrenox (Aspirin / Dipyridamole)

Magnitude and time course of platelet inhibition with extended release dipyridamole with or without aspirin in healthy Japanese volunteers. The AGgrenox versus Aspirin Therapy Evaluation (AGATE-Japan). [2008.01]

Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and leucocyte function in normal volunteers and patients with prior ischaemic stroke. [2005.03]

Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial. [2005]

Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination. [2004.09.28]

Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial. [2004.09.24]

more>>

Clinical Trials Related to Aggrenox (Aspirin / Dipyridamole)

JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme [Active, not recruiting]

Headache Study to Compare Aggrenox Full Dose and Reduced Dose [Completed]

EARLY 3-Months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA [Recruiting]

Vascular Access Clinical Trials Data Coordinating Center [Completed]

Treatment of Supine Hypertension in Autonomic Failure [Recruiting]

more>>